Metraipolis › archive › dc_4737d43eff35

Efficacy and safety evaluation of adalimumab for psoriatic arthritis: A meta-analysis — Europe PMC PMID:42629706

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42629706
DOI
10.1097/md.0000000000050295
License (as archived)
solo-consultazione
Archived
2026-10-17T06:21:24.059Z
SHA-256 of the archived text
a8be96e5357b03bddfabd543f92e15567c627e87bc18fc7c2453508a53786074
Stable URL of this page
https://metraipolis.com/documento/dc_4737d43eff35

How to cite

Efficacy and safety evaluation of adalimumab for psoriatic arthritis: A meta-analysis — Europe PMC PMID:42629706 — Europe PMC (en), https://europepmc.org/article/MED/42629706 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4737d43eff35 (Metraipolis archive dc_4737d43eff35, sha256 a8be96e5357b03bddfabd543f92e15567c627e87bc18fc7c2453508a53786074)
BibTeX
@misc{dc4737d43eff35,
  title = {Efficacy and safety evaluation of adalimumab for psoriatic arthritis: A meta-analysis — Europe PMC PMID:42629706},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42629706},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4737d43eff35; sha256 a8be96e5357b03bddfabd543f92e15567c627e87bc18fc7c2453508a53786074},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42629706. Agents can read the archived copy with the MCP tool read_document.